검색
Mainz Biomed NV
MYNZ관심 목록에 추가
0.844USD
0.0000.00%
종가 07/01, 16:00（ET）시세는 15분 지연됩니다
35.06M시가총액
손실P/E TTM
자세한 내용은 Mainz Biomed NV 회사
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.
Mainz Biomed NV 정보
종목 코드 MYNZ
회사 이름Mainz Biomed NV
상장일Nov 04, 2021
CEOBaechler (Guido)
직원 수19
유형Ordinary Share
회계 연도 종료Nov 04
주소Sirius Gutenberg Park
도시MAINZ
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가Germany
우편 번호55129
전화496131265140
웹사이트https://www.mainzbiomed.com/
종목 코드 MYNZ
상장일Nov 04, 2021
CEOBaechler (Guido)
Mainz Biomed NV의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Heiner Dreismann, Ph.D.
Dr. Heiner Dreismann, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
64.50K
+96.59%
Mr. Hans Hekland
Mr. Hans Hekland
Non-Executive Independent Director
Non-Executive Independent Director
56.00K
+68.27%
Mr. Gregory J. (Greg) Tibbitts
Mr. Gregory J. (Greg) Tibbitts
Non-Executive Independent Director
Non-Executive Independent Director
55.88K
+17.90%
Mr. Guido Baechler
Mr. Guido Baechler
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
6.36K
-9410.50%
Dr. Chris von Toerne
Dr. Chris von Toerne
Chief Operating Officer
Chief Operating Officer
2.50K
+93.24%
Mr. William Caragol
Mr. William Caragol
Chief Financial Officer
Chief Financial Officer
--
--
자주 묻는 질문
Mainz Biomed NV의 상위 5대 주주는 누구인가요?
Mainz Biomed NV의 상위 5대 주주는 다음과 같습니다: Dr. Heiner Dreismann, Ph.D.
Mainz Biomed NV(MYNZ)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Mainz Biomed NV의 주식을 보유한 기관은 총 33곳이며, 이들이 보유한 주식의 총 가치는 약 1.23M로 전체 발행 주식의 9.84%를 차지합니다. 이는 2025Q4 대비 663009.00 증가한 수치입니다.